Cutting-edge spatial multiomics technologies integrating protein and gene expression mapping, combined with AI-driven analysis, are revolutionizing cancer research by revealing the intricate architecture of tumor and immune cell interactions. Leica Biosystems highlights how these techniques enable researchers to dissect tumor heterogeneity, microenvironmental influences, and therapeutic response predictors. This progress promises advances in personalized oncology and improved treatment strategies.